Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Depreciation & Amortization (CF) (2016 - 2025)

Bio-Techne has reported Depreciation & Amortization (CF) over the past 17 years, most recently at $24.7 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $24.7 million for Q4 2025, down 8.77% from a year ago — trailing twelve months through Dec 2025 was $103.7 million (down 6.2% YoY), and the annual figure for FY2025 was $109.9 million, down 1.62%.
  • Depreciation & Amortization (CF) for Q4 2025 was $24.7 million at Bio-Techne, up from $24.3 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for TECH hit a ceiling of $28.5 million in Q3 2023 and a floor of $21.1 million in Q1 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $26.8 million (2022), compared with a mean of $26.2 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): rose 20.21% in 2022 and later decreased 13.49% in 2025.
  • Bio-Techne's Depreciation & Amortization (CF) stood at $25.1 million in 2021, then grew by 6.38% to $26.7 million in 2022, then rose by 4.12% to $27.8 million in 2023, then fell by 2.59% to $27.1 million in 2024, then fell by 8.77% to $24.7 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $24.7 million (Q4 2025), $24.3 million (Q3 2025), and $27.1 million (Q2 2025) per Business Quant data.